“…Expectations and predictions about CF shown as a serious problem in European countries and in studies on molecular treatment methods are that the number of adults with CF will increase by 70%, and the disease will gain more importance (15). In the first decade of life, the disease presents with bronchiectasis, exocrine pancreatic insufficiency, abnormal liver function tests, and meconium ileus; after the second decade, hemoptysis, pneumothorax, progressive lung failure, diabetes, cirrhosis, portal hypertension, and osteoporosis can be observed (1,9,15,16). Multidisciplinary approach and age-specific care services are important in patients with CF because of the effects of the disease on many systems and changes in this effect with age.…”